Fate Therapeutics (NASDAQ:FATE) on Thursday filed a prospectus related to a proposed resale of about 3.64M shares of its common stock by selling stockholders. This prospectus is not an offer to sell ...
Source LinkFate Therapeutics (NASDAQ:FATE) on Thursday filed a prospectus related to a proposed resale of about 3.64M shares of its common stock by selling stockholders. This prospectus is not an offer to sell ...
Source Link
Comments